Lifecore Biomedical, Inc. \De\ (LFCR) Other Accumulated Expenses (2011 - 2024)

Lifecore Biomedical, Inc. \De\'s Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $9.9 million for Q4 2024.

• In Q4 2024, Other Accumulated Expenses rose 28.85% year-over-year to $9.9 million; the TTM figure through Nov 2024 stood at $9.9 million (up 28.85% YoY), while the FY2024 annual figure was $9.4 million, up 30.97% from the prior year.
• Other Accumulated Expenses for Q4 2024 stood at $9.9 million, down from $11.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $13.0 million in Q1 2022, with the low at $3.0 million in Q2 2021.
• The 5-year median for Other Accumulated Expenses is $7.4 million (2023), against an average of $7.7 million.
• The sharpest annual moves came in 2020 and 2021: Other Accumulated Expenses surged 460.6% in 2020, then tumbled 69.84% in 2021.
• Lifecore Biomedical, Inc. \De\'s Other Accumulated Expenses stood at $6.1 million in 2020, then plunged by 36.55% to $3.9 million in 2021, then soared by 141.37% to $9.4 million in 2022, then declined by 18.24% to $7.7 million in 2023, then grew by 28.85% to $9.9 million in 2024.
• Business Quant data shows LFCR's Other Accumulated Expenses at $9.9 million in Q4 2024, $11.4 million in Q3 2024, and $9.4 million in Q2 2024.